HemaSphere (Jun 2022)
S200: IMPROVED OVERALL SURVIVAL WITH FIRST-LINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN PATIENTS WITH STAGE III/IV CLASSICAL HODGKIN LYMPHOMA: 6-YEAR ANALYSIS OF ECHELON-1
- M. Hutchings,
- S. M. Ansell,
- D. J. Straus,
- J. M. Connors,
- W. S. Kim,
- A. Gallamini,
- R. Ramchandren,
- J. W. Friedberg,
- R. Advani,
- A. M. Evens,
- P. Smolewski,
- K. J. Savage,
- N. L. Bartlett,
- H.-S. Eom,
- J. S. Abramson,
- C. Dong,
- F. Campana,
- K. Fenton,
- M. Puhlmann,
- J. Radford
Affiliations
- M. Hutchings
- 1 Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
- S. M. Ansell
- 2 Division of Hematology, Mayo Clinic, Rochester, MN
- D. J. Straus
- 3 Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America
- J. M. Connors
- 4 BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada
- W. S. Kim
- 5 Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
- A. Gallamini
- 6 Research and Innovation, Antoine-Lacassagne Cancer Centre, Nice, France
- R. Ramchandren
- 7 The University of Tennessee Graduate School of Medicine, Knoxville, TN
- J. W. Friedberg
- 8 James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
- R. Advani
- 9 Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
- A. M. Evens
- 10 Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States of America
- P. Smolewski
- 11 Department of Experimental Hematology, Medical University of Lodz, Lodz, Poland
- K. J. Savage
- 4 BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada
- N. L. Bartlett
- 12 Washington University School of Medicine Siteman Cancer Center, St Louis, MO, United States of America
- H.-S. Eom
- 13 Center for Hematologic Malignancy, National Cancer Center, Goyang, South Korea
- J. S. Abramson
- 14 Massachusetts General Hospital, Boston, MA
- C. Dong
- 15 Takeda Development Center Americas, Inc. (TDCA), Lexington MA
- F. Campana
- 15 Takeda Development Center Americas, Inc. (TDCA), Lexington MA
- K. Fenton
- 16 Seagen Inc., Bothell, WA, United States of America
- M. Puhlmann
- 16 Seagen Inc., Bothell, WA, United States of America
- J. Radford
- 17 The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
- DOI
- https://doi.org/10.1097/01.HS9.0000843692.94815.d7
- Journal volume & issue
-
Vol. 6
pp. 101 – 102
Abstract
No abstracts available.